XenoTherapeutics acquires Repare Therapeutics

XenoTherapeutics agreed to acquire Repare Therapeutics. Reported deal value: Undisclosed. Status: Pending. Sector: Biotechnology. Target headquarters context: Montreal, Quebec, Canada.

This page summarizes publicly available information about the transaction as of 2026-01-19. Figures and status may change as filings and press coverage update.

Repare Therapeutics Inc. , a clinical-stage precision oncology company, today announced that its Shareholders have approved the acquisition of all of the issued and outstanding common shares of the Company by Xeno Therapeutics , Inc. and Xeno Acquisition Corp . a non-profit biotechnology company, by way of a statutory plan of arrangement at the special meeting of Shareholders held today